Management team due diligence: will the people behind the plan actually deliver?

Whether you are deciding to invest or deciding who sits in a leadership seat, the hard question is the same. Can these people execute what the proposal says, work together under pressure, and use the company's resources the way the plan assumes?

A strong pitch deck does not answer that. A strong résumé does not either. The risk shows up later, after the capital is committed or the offer is signed.

How do investors evaluate a startup's leadership team?

Investors evaluate whether the people can execute what the proposal says, not only whether the proposal is sound. They face a gap between what a company promises and what its people can actually do. The proposal may be sound. The team may still struggle to execute it, misallocate funds, or stall when the plan meets the real market.

Founders face a different version of the same problem. You need to build a team or place a new leader into a culture that already exists. The wrong hire burns runway, slows growth, and forces hard conversations with your board. Familiarity is not fit. A great interview is not proof of execution. Talent is only part of it. Positive Intelligence found that teams with a PQ Score above 75 perform 31% better on average when other factors are equal.

It rarely sounds like a request for an assessment. It sounds like this: "We have funding and twelve months to hit these milestones. Can this team get us there?" Or: "The founders keep disagreeing, and important decisions are slipping." Or: "Our CEO is brilliant, but everything still goes through her."

What you need depends on which side of the decision you are on.

Two healthcare co-founders in a tense but respectful disagreement at a meeting table while a third leader looks on

The assessments behind it

Each path draws on established assessment tools with their own published track records.

The Predictive Index is a behavioral assessment used by more than 10,000 clients in over 90 countries.

Positive Intelligence reports that teams with a PQ Score above 75 perform 31% better on average when other factors are equal.

Two paths: investor and founder

PulsePoint Path offers an investor-facing filter and two founder-facing programs. They share a focus on execution. They answer different questions and deliver different outputs.

Executive Risk Filter (investor-facing)

The Executive Risk Filter helps an investor decide whether to put money behind a company. It checks whether the team can execute what its proposal says and use the funds correctly. Capable individuals do not automatically form a capable leadership team, and new funding can expose or deepen weaknesses in how leaders work together. The filter shows whether this team can carry the investment plan and where support is needed if it cannot.

You get an individual ExecutionDNA Essence report for each person assessed, plus a phase 1 Team capability report. The filter does not include a job role description or a 90-day onboarding strategy. Those belong to the founder-facing programs, where the next step is building or placing people, not deciding on capital.

ExecutionDNA Team (founder-facing)

ExecutionDNA Team is for founders who are building the team. It helps you see how people fit together, where friction is likely, and how to structure roles so the team can execute as the company grows.

It includes a job role description and a 90-day onboarding strategy that covers Team phase 2 and 3 planning. It helps answer questions like which senior role to fill first, and whether the next hire should be a COO, a sales leader, or someone else.

ExecutionDNA Leadership (founder-facing)

ExecutionDNA Leadership is for founders placing a new leader into an existing culture. It looks at how compatible that person is with the team already in place, and whether they can help the company scale.

It includes a job role description and a 90-day onboarding strategy that covers Team phase 2 and 3 planning. It helps answer questions like whether the CEO is still the bottleneck, and what the founder should own, delegate, or get support on.

What each includes

Include	Executive Risk Filter	ExecutionDNA Team	ExecutionDNA Leadership
Facing	Investor	Founder	Founder
Focus	Can the team execute the proposal and use funds correctly?	Building the team	Placing a new leader into an existing culture
Individual Essence reports and phase 1 Team capability	Yes	No	No
Job role description and 90-day onboarding strategy	No	Yes	Yes

Who it is for

The Executive Risk Filter is for investors evaluating a healthcare, wellness, or dental company before committing capital.

ExecutionDNA Team and ExecutionDNA Leadership are for founders and CEOs of those same companies who are building a team or placing a new leader into a seat that will shape how the company scales.

A healthcare founder shaking hands with a newly hired senior executive in a modern office while the existing team looks on

What you get

What you receive depends on the path.

Executive Risk Filter

An individual ExecutionDNA Essence report for each person assessed
A phase 1 Team capability report on whether the team can execute the proposal and use funds correctly

ExecutionDNA Team and ExecutionDNA Leadership

Clarity on team fit or leadership compatibility for the decision in front of you
A job role description
A 90-day onboarding strategy that covers Team phase 2 and 3 planning

Frequently asked questions

Is the Executive Risk Filter the same as the Founder Execution Risk Filter?

Yes. Same product, investor-facing name. It helps an investor decide whether to put money behind a company by checking whether the team can execute what its proposal says.

How is this different from a background check?

A licensed screening provider should handle background checks. These programs start where screening stops. Most companies need both.

Which program should I choose?

If you are deciding whether to invest, start with the Executive Risk Filter. If you are a founder building a team, choose ExecutionDNA Team. If you are placing a new leader into an existing culture, choose ExecutionDNA Leadership.

Should our next hire be a COO or a sales leader?

Decide after you see how the current team fits together and where execution is exposed. ExecutionDNA Team helps answer which senior role to fill first, and whether the next hire should be a COO, a sales leader, or someone else.

How do you onboard a new executive into an existing culture?

Start by checking how compatible the new leader is with the team already in place, then follow a 90-day plan. ExecutionDNA Leadership includes a job role description and a 90-day onboarding strategy that covers Team phase 2 and 3 planning.

How do I know if the founder is the bottleneck?

A common sign is that everything still goes through the founder and important decisions are slipping. ExecutionDNA Leadership helps answer whether the CEO is still the bottleneck, and what the founder should own, delegate, or get support on.

Do Team and Leadership include the same deliverables as the Risk Filter?

No. The Risk Filter delivers individual Essence reports and a phase 1 Team capability report. Team and Leadership include a job role description and a 90-day onboarding strategy. The Risk Filter does not.

Where can I learn more about building a healthcare leadership team?

Read our leadership articles or meet operators and advisors at an upcoming event.

What will I be able to decide when it is done?

You will know where the team can deliver, where execution is exposed, and what to change first. That might mean clarifying who owns an outcome, setting decision limits, developing a leader, or filling a specific role. Every finding is tied to the next business milestone, because a team's fit depends on what it has to accomplish.